All In Biotech

Drug Trial Radar · NCT00702507

Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants

Prospective 2-Year Longitudinal Study to Assess for Miconazole Resistance in Candida Spp. With Repeated Treatment Courses of 0.25% Miconazole Nitrate Ointment in Neonates and Infants up to 1 Year of Age With Recurrent Moderate-Severe Diaper Dermatitis Complicated by Cutaneous Candidiasis

Last checked: Nov 19, 2026Latest source record: Mar 27, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

200

Actual

Start

May 2007

Primary completion

Dec 2010

Study completion Dec 2010

Sponsor

Lead sponsor
Stiefel, a GSK CompanyIndustry
Sponsor type
Industry
Collaborators
GlaxoSmithKline
First posted
Jun 20, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, up to 15 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether repeated use of 0.25% miconazole nitrate ointment in newborns and infants with a yeast infection in the diaper area causes the yeast to become resistant to the drug.

Conditions

  • Diaper Rash

Interventions

  • 0.25 % Miconazole Nitrate OintmentDrug

    Topical Application

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Overall Cure (OC)Time frame: Test-of-cure visit (Day 14) of initial treatment episode

Locations

8 sites in 4 countries. Site status is shown where the registry gives one.

  • Sheila Fallon Friedlander, MD

    San Diego, California

  • David Rodriguez, MD

    Coral Gables, Florida

  • Lawrence Schachner, MD

    Miami, Florida

  • Wilson P. Andrews Jr., MD

    Marietta, Georgia

  • Lewis Purnell, MD

    San Antonio, Texas

  • Daisy Blanco, MD

    Santo Domingo, Dominican Republic

  • Manuel Briones, MD

    Guayaquil, Ecuador

  • Zila Espinosa, MD

    Panama City, Panama

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.